Fortress Biotech, Inc. (NASDAQ:FBIOP) Sees Large Growth in Short Interest

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totaling 1,600 shares. Based on an average daily volume of 20,345 shares, the short-interest ratio is currently 0.1 days.

Fortress Biotech Stock Performance

Fortress Biotech stock traded down $0.91 during trading hours on Wednesday, reaching $16.50. 9,840 shares of the company’s stock were exchanged, compared to its average volume of 19,643. The firm’s 50 day simple moving average is $18.16 and its 200 day simple moving average is $17.51. Fortress Biotech has a twelve month low of $6.27 and a twelve month high of $21.43.

About Fortress Biotech

Fortress Biotech, Inc is a biopharmaceutical company focused on developing and commercializing medicines for serious diseases with significant unmet medical needs. The company uses a subsidiary-based business model in which specialized biotechnology companies advance therapies in areas including oncology, dermatology, rare diseases, infectious diseases and neurology.

Fortress and its subsidiaries develop products across multiple stages, from early research and clinical development to regulatory approval and commercialization.